Insulin action and secretion independent of traditional risk factors predict new-onset type 2 diabetes in Iraqi and Swedish born citizens - The MEDIM cohort study.
clinical diabetes
epidemiology
insulin secretion in vivo
insulin sensitivity and resistance
prediction and prevention of type 2 diabetes
socioeconomic aspects
Journal
Diabetes/metabolism research and reviews
ISSN: 1520-7560
Titre abrégé: Diabetes Metab Res Rev
Pays: England
ID NLM: 100883450
Informations de publication
Date de publication:
03 2022
03 2022
Historique:
revised:
20
10
2021
received:
11
05
2021
accepted:
21
10
2021
pubmed:
28
10
2021
medline:
1
4
2022
entrez:
27
10
2021
Statut:
ppublish
Résumé
Our aim was to study the incidence of type 2 diabetes in a population-based cohort of Swedish and Iraqi born individuals, focussing on traditional risk factors, insulin action, insulin secretion and ethnicity. The cohort consisted of 1164 Iraqi and 693 Swedish-born citizens. We investigated the association between new-onset type 2 diabetes and the predictors including lifestyle factors, metabolic risk markers, country of birth, insulin sensitivity and secretion assessed by Matsuda index with Cox regression. Eighty-nine individuals were diagnosed with type 2 diabetes with a mean follow-up of 7.5 years. Both lower insulin sensitivity (ISI, HR 0.02 [0.01-0.08]) as well as insulin secretion (CIR, HR 0.13 [0.07-0.24]) at baseline predicted type 2 diabetes onset, independent of traditional risk factors. Our results were not modified by country of birth. Regarding traditional risk factors, WHR (1.05 [1.00-1.09]), blood glucose (3.27 [2.35-4.55]), LDL/HDL (1.46 [1.20-1.78]) and diastolic blood pressure (1.04 [1.00-1.07]) predicted diabetes incidence in the full model. Both impaired insulin sensitivity index and corrected insulin response predicted type 2 diabetes onset, independent of traditional risk factors. We conclude that insulin secretion and action might be useful additional predictors for type 2 diabetes in populations of European and Middle Eastern ethnicities.
Substances chimiques
Blood Glucose
0
Insulin
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e3509Informations de copyright
© 2021 The Authors. Diabetes/Metabolism Research and Reviews published by John Wiley & Sons Ltd.
Références
Lam DW, LeRoith D. The worldwide diabetes epidemic. Curr Opin Endocrinol diabetes, Obes. 2012;19(2):93-96.
Chiha M, Njeim M, Chedrawy EG. Diabetes and coronary heart disease: a risk factor for the global epidemic. Int J Hypertens. 2012;2012:697240.
Wandell PE, Carlsson A, Steiner KH. Prevalence of diabetes among immigrants in the Nordic countries. Curr diabetes Rev. 2010;6(2):126-133.
Wandell PE, Wajngot A, de Faire U, Hellenius ML. Increased prevalence of diabetes among immigrants from non-European countries in 60-year-old men and women in Sweden. Diabetes Metab. 2007;33(1):30-36.
Bennet L, Udumyan R, Ostgren CJ, Rolandsson O, Jansson SPO, Wandell P. Mortality in first- and second-generation immigrants to Sweden diagnosed with type 2 diabetes: a 10 year nationwide cohort study. Diabetologia. 2021;64(1):95-108.
Reis JP, Loria CM, Sorlie PD, Park Y, Hollenbeck A, Schatzkin A. Lifestyle factors and risk for new-onset diabetes: a population-based cohort study. Ann Intern Med. 2011;155(5):292-299.
Bennet L, Groop L, Lindblad U, Agardh CD, Franks PW. Ethnicity is an independent risk indicator when estimating diabetes risk with FINDRISC scores: a cross sectional study comparing immigrants from the Middle East and native Swedes. Prim Care Diabetes. 2014;8(3):231-238.
Kitabchi AE, Temprosa M, Knowler WC, et al. Role of insulin secretion and sensitivity in the evolution of type 2 diabetes in the diabetes prevention program: effects of lifestyle intervention and metformin. Diabetes. 2005;54(8):2404-2414.
Abdul-Ghani MA, Williams K, DeFronzo RA, Stern M. What is the best predictor of future type 2 diabetes? Diabetes Care. 2007;30(6):1544-1548.
Bennet L, Groop L, Franks PW. Ethnic differences in the contribution of insulin action and secretion to type 2 diabetes in immigrants from the Middle East compared to native Swedes. Diabetes Res Clin Pract. 2014;105(1):79-87.
Bennet L, Nilsson C, Mansour-Aly D, Christensson A, Groop L, Ahlqvist E. Adult-onset diabetes in Middle Eastern immigrants to Sweden: novel subgroups and diabetic complications-The All New Diabetes in Scania cohort diabetic complications and ethnicity. Diabetes Metab Res Rev. 2020;37(6):e3419.
Matsuda M, DeFronzo RA. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care. 1999;22(9):1462-1470.
Bennet L, Agardh CD, Lindblad U. Cardiovascular disease in relation to diabetes status in immigrants from the Middle East compared to native Swedes: a cross-sectional study. BMC Publ Health. 2013;13:1133.
Socialstyrelsen. The National Patient Register. Accessed November 04, 2020. https://www.socialstyrelsen.se/en/statistics-and-data/registers/register-information/the-national-patient-register/
Gudbjornsdottir S, Cederholm J, Nilsson PM, Eliasson B. Steering committee of the Swedish National diabetes R. The National diabetes register in Sweden: an implementation of the St. Vincent declaration for quality improvement in diabetes care. Diabetes Care. 2003;26(4):1270-1276.
Wallace TM, Levy JC, Matthews DR. Use and abuse of HOMA modeling. Diabetes Care. 2004;27(6):1487-1495.
Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28(7):412-419.
Patel TP, Rawal K, Bagchi AK, et al. Insulin resistance: an additional risk factor in the pathogenesis of cardiovascular disease in type 2 diabetes. Heart Fail Rev. 2016;21(1):11-23.
Sampath Kumar A, Maiya AG, Shastry BA, et al. Exercise and insulin resistance in type 2 diabetes mellitus: a systematic review and meta-analysis. Ann Phys Rehabil Med. 2019;62(2):98-103.
Knowler WC, Barrett-Connor E, Fowler SE, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N. Engl J Med. 2002;346(6):393-403.
Artese A, Stamford BA, Moffatt RJ. Cigarette smoking: an accessory to the development of insulin resistance. Am J lifestyle Med. 2019;13(6):602-605.
Eliasson B, Attvall S, Taskinen MR, Smith U. Smoking cessation improves insulin sensitivity in healthy middle-aged men. Eur J Clin Invest. 1997;27(5):450-456.
Stadler M, Tomann L, Storka A, et al. Effects of smoking cessation on beta-cell function, insulin sensitivity, body weight, and appetite. Eur J Endocrinol/Societies. 2014;170(2):219-227.
Rhee MK, Ho Y-L, Raghavan S, et al. Random plasma glucose predicts the diagnosis of diabetes. PloS One. 2019;14(7):e0219964.
Kahn BB, Flier JS. Obesity and insulin resistance. J Clin Invest. 2000;106(4):473-481.
Haghighatdoost F, Amini M, Feizi A, Iraj B. Are body mass index and waist circumference significant predictors of diabetes and prediabetes risk: results from a population based cohort study. World J diabetes. 2017;8(7):365-373.
Bennet L, Stenkula K, Cushman SW, Brismar K. BMI and waist circumference cut-offs for corresponding levels of insulin sensitivity in a Middle Eastern immigrant versus a native Swedish population - the MEDIM population based study. BMC Publ Health. 2016;16(1):1242.
Lindstrom J, Tuomilehto J. The diabetes risk score: a practical tool to predict type 2 diabetes risk. Diabetes Care. 2003;26(3):725-731.
Fizelova M, Jauhiainen R, Stancakova A, Kuusisto J, Laakso M. Finnish diabetes risk score is associated with impaired insulin secretion and insulin sensitivity, drug-treated hypertension and cardiovascular disease: a follow-up study of the METSIM cohort. PloS One. 2016;11(11):e0166584.
Fokkens BT, van Waateringe RP, Mulder DJ, Wolffenbuttel BHR, Smit AJ. Skin autofluorescence improves the Finnish Diabetes Risk Score in the detection of diabetes in a large population-based cohort: the LifeLines Cohort Study. Diabetes Metab. 2018;44(5):424-430.